Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice
- PMID: 15082918
- DOI: 10.1023/B:JOMG.0000023588.55733.84
Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice
Abstract
The cyclin-dependent kinase inhibitor p27 (Kip1) is an important cell cycle regulatory gene in breast cancer, and decreased p27 expression is associated with poor prognosis. Some investigations of its role in mammary development have demonstrated reduced cyclin D1 expression and consequent lack of lobuloalveolar development, but others have found increased cyclin E-Cdk2 activity and increased proliferation balanced by increased apoptosis. It is unclear at present why these apparently divergent results have been obtained. Mice with reduced p27 gene dosage alone do not develop mammary carcinomas but do display substantially shorter tumor latency upon overexpression of erbB2, consistent with a role for p27 as a mammary tumor suppressor gene. In this review we summarize these and other data addressing the role of p27 in normal mammary epithelium and experimental models of mammary carcinogenesis.
Similar articles
-
ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells.Mol Cell Biol. 2002 Apr;22(7):2204-19. doi: 10.1128/MCB.22.7.2204-2219.2002. Mol Cell Biol. 2002. PMID: 11884607 Free PMC article.
-
Cell cycle genes in a mouse mammary hyperplasia model.J Mammary Gland Biol Neoplasia. 2004 Jan;9(1):81-93. doi: 10.1023/B:JOMG.0000023590.63974.f8. J Mammary Gland Biol Neoplasia. 2004. PMID: 15082920 Review.
-
The cyclin-dependent kinase inhibitor p27 (Kip1) regulates both DNA synthesis and apoptosis in mammary epithelium but is not required for its functional development during pregnancy.Mol Endocrinol. 2003 Dec;17(12):2436-47. doi: 10.1210/me.2003-0199. Epub 2003 Aug 21. Mol Endocrinol. 2003. PMID: 12933906
-
ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.Cancer Res. 2001 Sep 1;61(17):6583-91. Cancer Res. 2001. PMID: 11522658
-
Cyclins and breast cancer.J Mammary Gland Biol Neoplasia. 2004 Jan;9(1):95-104. doi: 10.1023/B:JOMG.0000023591.45568.77. J Mammary Gland Biol Neoplasia. 2004. PMID: 15082921 Review.
Cited by
-
Role of phosphorylation in progesterone receptor signaling and specificity.Mol Cell Endocrinol. 2012 Jun 24;357(1-2):43-9. doi: 10.1016/j.mce.2011.09.017. Epub 2011 Sep 16. Mol Cell Endocrinol. 2012. PMID: 21945472 Free PMC article. Review.
-
Changes in the cellular microRNA profile by the intracellular expression of HIV-1 Tat regulator: A potential mechanism for resistance to apoptosis and impaired proliferation in HIV-1 infected CD4+ T cells.PLoS One. 2017 Oct 2;12(10):e0185677. doi: 10.1371/journal.pone.0185677. eCollection 2017. PLoS One. 2017. PMID: 28968466 Free PMC article.
-
Genetic screening reveals an essential role of p27kip1 in restriction of breast cancer progression.Cancer Res. 2007 Sep 1;67(17):8032-42. doi: 10.1158/0008-5472.CAN-07-0083. Cancer Res. 2007. PMID: 17804714 Free PMC article.
-
Attenuation of cell cycle regulator p27(Kip1) expression in vertebrate epithelial cells mediated by extracellular signals in vivo and in vitro.J Comp Physiol B. 2005 Oct;175(7):511-22. doi: 10.1007/s00360-005-0019-x. Epub 2005 Oct 26. J Comp Physiol B. 2005. PMID: 16075271
-
Immunohistochemical demonstration of histone H1(0) in human breast carcinoma.Histochem Cell Biol. 2005 Nov;124(5):435-43. doi: 10.1007/s00418-005-0052-6. Epub 2005 Nov 3. Histochem Cell Biol. 2005. PMID: 16158288
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous